Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
China National Institute of Pharmaceutical R&D (NIPRD) is a leading pharmaceutical research and development organization based in Beijing, operating as a core subsidiary of the China National Pharmaceutical Group (Sinopharm). The institute focuses on the discovery and development of innovative drugs, generic medications, and advanced drug delivery systems across various therapeutic areas including oncology and infectious diseases. NIPRD provides comprehensive R&D services, including medicinal chemistry, pharmacology, toxicology, and clinical trial management, supporting both internal Sinopharm projects and external clients. As a national-level research center, it plays a pivotal role in advancing China's pharmaceutical industry through technology transfer and the modernization of traditional Chinese medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on The National Institutes of Pharmaceutical R&D.